$FRPT

Piper Sandler reiterates Freshpet stock rating on sales growth

Piper Sandler reiterated an Overweight rating and $87 price target on Freshpet (FRPT), citing expected Q3 2026 sales growth exceeding estimates. The company reported 8.6% Q3 2026 U.S. retail sales growth, with significant increases at Costco. Piper Sandler projects Q3 2026 EBITDA margin at 18.5%, below Street estimates. FRPT stock has declined 25% since August, trading at $60.01, with a Fair Value estimate of $76.81.

Original reporting
Published Oct 5, 2026, 1:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 1:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$FRPT
Bullish
medium confidence
Mentioned
$FRPT
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$FRPTBullishLow
01

Why it matters

The reiteration of an Overweight rating and a higher price target may attract short-term buying, but the news adds little new fundamental data.

02

Market read

Analyst rating update with modest upside potential for Freshpet; limited broader market effect.

03

What to watch

Potential headwinds from reduced shipments at Sam’s Club and competitive pressure are not fully reflected.

Relevance 4/10Novelty 2/10Timing: today

Background

The article summarizes Piper Sandler's analyst coverage of Freshpet ahead of its upcoming Q3 earnings.

Company-level read

Ticker impact

$FRPTBullishMedium confidence
Context

Piper Sandler reiterated an Overweight rating and $87 price target for Freshpet, citing strong sales growth ahead of Q3 2026 earnings.

Expected impact

likely upward pressure as investors price in the higher target and overweight rating

Evidence & confidence

The rating change is new but based on existing sales trends; impact is limited to sentiment-driven moves.

Market effects

May boost sentiment in the pet food sector as analysts highlight growth potential.

Limited to U.S. equities, no broader regional effect.

Minimal global impact beyond Freshpet and its peers.

Counterpoint

The rating could be premature if sales growth slows or competition intensifies.

Key entities

  • Freshpet

    Pet food manufacturer (NASDAQ:FRPT).

  • Piper Sandler

    Equity research firm providing the rating.

Related articles

$FRPTMed

Perishable Food Q2 Earnings: Mission Produce (NASDAQ:AVO) is the Best in the Biz

Freshpet (FRPT) reported Q2 revenue of $305.6M, up 15.5% YoY, beating estimates. Cal-Maine (CALM) saw revenue drop 41.5% YoY to $539.6M, missing expectations. Pilgrim's Pride (PPC) reported $4.63B revenue, down 2.8% YoY, also missing estimates. United Natural Foods (UNFI) reported flat revenue at $7.64B, slightly missing expectations. All stocks except UNFI are down since reporting.

$CALMMed

Maine (NASDAQ:CALM) Vs The Rest Of The Perishable Food Stocks

Cal-Maine Foods (CALM) reported Q2 revenue of $552.6M, down 49.9% YoY, missing estimates by 2%. Mission Produce (AVO) reported $450M revenue, up 25.8% YoY, beating estimates. Flowers Foods (FLO) and Tyson Foods (TSN) missed estimates. Freshpet (FRPT) reported $305.6M revenue, up 15.5% YoY, beating estimates. Perishable food stocks are down 8.8% on average since earnings.

$FRPTMed

Freshpet at barclays consumer conference: rivals, margins and growth

Freshpet (FRPT) discussed growth and strategy at the Barclays Global Consumer Conference. The company noted increased competition but believes category growth benefits it. Key points include omni-channel sales, manufacturing tech, and focus on high-value customers. Freshpet reiterated 2027 targets of 49% adjusted gross margin and 20-22% adjusted EBITDA margin. Shares trade at $67.21 with a $3.23B market cap.